How has Anterix's right of use assets modifications and renewals changed year-over-year?

Anterix's right of use assets modifications and renewals decreased by 98.8% year-over-year, from $850K to $10K.

Anterix ATEX Right of use assets modifications and renewals

Revenue$2.0M+41.0%

Gross profit$608.0K+81.5%

Operating income$19.8M—

Net income$18.5M—

EPS (diluted)$0.98—

Cash & equivalents$98.5M+108%

Total debt$4.4M-18.0%

Total equity$262.3M+67.5%

Total assets$465.2M+39.7%

Operating cash flow$15.5M+194%

CapEx$22.0K-52.2%

Free cash flow$15.5M+193%

Market cap$1.5B+190%

Enterprise value$1.4B+196%

P/E16.5×—

P/S230.1×+145×

Gross margin-105.3%—

Operating margin1,444.9%—

Net margin1,394.2%—

FCF margin-486.7%-1,481pp

Return on equity43.3%—

Debt / equity0×0.0×

Current ratio3.3×+1.1×

Reported directly by Anterix in its filing.

Tagged under the XBRL concept atex:RightsOfUseAssetForModificationsAndRenewals.

The official record: Anterix’s 10-Q, filed November 12, 2025, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is Anterix's right of use assets modifications and renewals?: Anterix (ATEX) reported right of use assets modifications and renewals of $10K in Q3 2025.
How has Anterix's right of use assets modifications and renewals changed year-over-year?: Anterix's right of use assets modifications and renewals decreased by 98.8% year-over-year, from $850K to $10K.